Intrommune Logo Only - 250k.jpg
Intrommune Participates in 2019 Food Allergy Fund Summit
November 26, 2019 15:41 ET | Intrommune Therapeutics
New York, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment for peanut and other food allergies delivered...
Intrommune Logo Only - 250k.jpg
POISED Study Supports Risk of Cessation of Oral Immunotherapy for Peanut Allergy; PACE Study Indicates Safer Peanut Allergy Treatment Approaches are Needed
November 07, 2019 10:00 ET | Intrommune Therapeutics
New York, Nov. 07, 2019 (GLOBE NEWSWIRE) -- A major study recently published in The Lancet, “Sustained outcomes in oral immunotherapy for peanut allergy (POISED study),” further validates the...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote
September 16, 2019 14:25 ET | Intrommune Therapeutics
New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Support from Allergy & Asthma Network
September 13, 2019 09:05 ET | Intrommune Therapeutics
New York, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing the patient-friendly oral mucosal immunotherapy (OMIT) toothpaste platform for...
Intrommune Logo Only - 250k.jpg
Newly Published Findings Validate Intrommune’s Approach to Treating Peanut and Other Food Allergies
September 05, 2019 15:20 ET | Intrommune Therapeutics
New York, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Formulation Patent Notice of Allowance
August 21, 2019 14:41 ET | Intrommune Therapeutics
New York, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
MN Health Fairs.jpg
Health Fair 11 at the Fair Offers Healthy Options to State Fair Goers
August 15, 2019 17:35 ET | Minnesota Health Fairs Inc.
GOLDEN VALLEY, Minn., Aug. 15, 2019 (GLOBE NEWSWIRE) -- The Minnesota State Fair is all about tradition. Fairgoers have their must-eat food(s!), their tried-and-true route around the fairgrounds,...
Food Allergies Are T
Food Allergies Are Top Concern for Families As They Prepare for Back-to-School
August 15, 2019 08:21 ET | Asthma and Allergy Foundation of America
Washington, D.C., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Today, the Asthma and Allergy Foundation of America (AAFA) released a report of findings from its “My Life With Food Allergy” study. As children...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference
May 17, 2019 13:25 ET | Intrommune Therapeutics
New York, May 17, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing patient-friendly food allergy therapies for peanut and other food allergies...
DAO-To-Go
Quick Umbrellux DAO Test Reveals If That Reaction Is Really Histamine Intolerance And Not A Food Allergy
May 13, 2019 09:30 ET | Umbrellux DAO
ANN ARBOR, Mich., May 13, 2019 (GLOBE NEWSWIRE) -- Food Allergy Awareness Week is the perfect time to determine if you may be mislabeling your body’s reaction to certain foods. Umbrellux DAO offers...